Leading Biopharmaceutical Technology Surges Over 240% Intraday After Announcing Plans to Acquire Full Equity of Conflux
Odaily Planet Daily reported that Hong Kong-listed company Leading Pharma-Biotech (00399) saw a surge in trading volume and a sharp rise in its share price during early trading today, with an intraday increase of nearly 240% and a peak price of HK$0.7, before retreating to around HK$0.34.
Previously, the company announced plans to acquire all equity in the blockchain project Conflux to expand its presence in the blockchain sector. Two founding members of Conflux currently serve as its executive directors.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
HYPE completes its first massive unlock, token price remains stable without significant fluctuations
Arthur Hayes responds to Monad co-founder: Unlock all tokens now and you will definitely succeed
Nasdaq executive: Tokenized stock plan is being actively advanced, with SEC approval listed as the top priority
Trending news
MoreCrypto prices
More
